Phase 2 Trial (POLA Study) of lurbinectedin plus olaparib in patients with advanced solid tumors: results of efficacy, tolerability, and the translational study

Poveda, Andrés; López-Reig, Raquel; Oaknin, Ana; Redondo Sánchez, Andrés; Rubio, Maria Jesús; Guerra, Eva; Fariñas-Madrid, Lorena; Gallego, Alejandro; Rodriguez-Freixinos, Víctor; Fernandez-Serra, Antonio; Juan, Oscar; Romero, Ignacio; López Guerrero, José Antonio

UAM_Biblioteca

Author

Poveda, Andrés; López-Reig, Raquel; Oaknin, Ana; Redondo Sánchez, Andrés

; Rubio, Maria Jesús; Guerra, Eva; Fariñas-Madrid, Lorena; Gallego, Alejandro; Rodriguez-Freixinos, Víctor; Fernandez-Serra, Antonio; Juan, Oscar; Romero, Ignacio; López Guerrero, José Antonio

Entity

UAM. Departamento de Medicina

Publisher

MDPI

Date

2022-02-12

Citation

Cancers 14.4 (2022): 915

ISSN

2072-6694

DOI

10.3390/cancers14040915

Editor's Version

https://doi.org/10.3390/cancers14040915

Subjects

Endometrial cancer; Genomic instability; Lurbinectedin; Olaparib; Ovarian cancer; Medicina

URI

http://hdl.handle.net/10486/703782

Rights

Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional.

Show full item record

Files in this item

Name

9048687.pdf

Size

1.607Mb

Format

PDF

Google™ Scholar:Poveda, Andrés - López-Reig, Raquel - Oaknin, Ana - Redondo Sánchez, Andrés - Rubio, Maria Jesús - Guerra, Eva - Fariñas-Madrid, Lorena - Gallego, Alejandro - Rodriguez-Freixinos, Víctor - Fernandez-Serra, Antonio - Juan, Oscar - Romero, Ignacio - López Guerrero, José Antonio

This item appears in the following Collection(s)

Producción científica en acceso abierto de la UAM [16522]

UAM_Biblioteca

Phase 2 Trial (POLA Study) of lurbinectedin plus olaparib in patients with advanced solid tumors: results of efficacy, tolerability, and the translational study

Author

Entity

Publisher

Date

Citation

ISSN

DOI

Editor's Version

Subjects

URI

Rights

Files in this item

This item appears in the following Collection(s)

Related items

Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients ﻿

A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial ﻿

Molecular characterization and clinical impact of TMPRSS2-ERG rearrangement on prostate cancer: comparison between FISH and RT-PCR ﻿

Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients

A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial

Molecular characterization and clinical impact of TMPRSS2-ERG rearrangement on prostate cancer: comparison between FISH and RT-PCR